How to best ensure the technology transfer of vaccine processes
Sponsored by: Sartorius Stedim Biotech
- Technology Transfer
Date: 5 November
Time: 3PM London/10AM New York
Enabling fast & robust vaccine technology transfer with single use solutions and predictive process control
In an increasingly globalised world, the promise of technology transfer is a key consideration for all countries whether in low, middle and high income countries. However, technology transfer of a vaccine manufacturing process can be very challenging, and any inefficiency in technology transfer results in serious loss of time and resources. Therefore, aspects such as process scale up/scale down, complexity reduction, process validation and process understanding are critical for a successful process transfer.
This presentation will underline the common pitfalls in technology transfers and describe how the use of high throughput multi parallel ambrÂ® testing systems and design of experiment software can facilitate the technology transfer. These automated scale up and scale down tools able to explore a wide range of conditions for both the upstream and downstream process steps help achieve vaccine process transfers in a fast, efficient and reliable way.
The presenter will then show how the implementation of single use technologies, process analytical technologies and SIMCAÂ®-on line multi variate monitoring tools can increase process flexibility, safety and lead to improved processes which deliver the expected manufacturing outcome in receiving units.
You are a sending or a receiving site, you are interested in identifying the main challenges and in getting some key drivers such as single use solutions and predictive process control for a fast and robust technology transfer, please register to this webinar presentation.
Marketing Manager – Traditional vaccines
Carole Langlois started her career in 1996 with Abbott Laboratories in Chicago, US. In 1998, she joined Sartorius Stedim Biotech in Aubagne, France where she is today Marketing Manager – Traditional vaccines. Carole has 20 years of experience in the Pharmaceutical and Biopharmaceutical industries and has been involved in many industrial projects for the integration of single-use systems (SUS) in Form, Fill & Finish processes. As of 2012, she has been working on the integrity control strategy for SUS. Carole is a member of the PDA, the BPSA and the ASTM E55 task force for the creation of recommendations and standards for SUS integrity testing.
Carole Langlois holds a Biotechnology university degree from Polytech Marseille and an Executive Master of Business Administration (MBA) from Kedge Business School Marseille.
Key Learning Objectives
- Highlight the main challenges and obstacles in technology transfer
- Review single use technologies facilitating faster technology transfer
- Discover analytical tools as key quality attributes for robust technology transfer
- Learn about scale-down tools for troubleshooting
- Advisory / Consulting
- Product Management
- Research & Development
- Senior Management
- Information Technology